Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes
暂无分享,去创建一个
Casey S Greene | Chen Wang | Ellen L Goode | Brooke L Fridley | James Rudd | Gregory P. Way | Gregory P Way | B. Fridley | E. Goode | C. Greene | Chen Wang | J. Doherty | G. Konecny | James Rudd | H. Hamidi | Habib Hamidi | Jennifer A Doherty | Gottfried E Konecny | G. Way
[1] R. Sokal,et al. THE COMPARISON OF DENDROGRAMS BY OBJECTIVE METHODS , 1962 .
[2] L. Rasmussen,et al. Functional Genomics , 2012, Methods in Molecular Biology.
[3] C. Planey,et al. CoINcIDE: A framework for discovery of patient subtypes across multiple datasets , 2016, Genome Medicine.
[4] Carl Boettiger,et al. An introduction to Docker for reproducible research , 2014, OPSR.
[5] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[6] E. Goode,et al. Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer. , 2014, Journal of the National Cancer Institute.
[7] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] Wing H Wong,et al. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. , 2005, Cancer research.
[9] Pablo Tamayo,et al. Metagenes and molecular pattern discovery using matrix factorization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Tothill,et al. Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome , 2008, Clinical Cancer Research.
[11] I. Shih,et al. Ovarian Low-grade and High-grade Serous Carcinoma: Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems , 2009, Advances in anatomic pathology.
[12] Anne-Marie Mes-Masson,et al. Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling , 2005, Oncogene.
[13] Tatsuhiko Tsunoda,et al. High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway , 2012, Clinical Cancer Research.
[14] S. Silverberg. Histopathologic grading of ovarian carcinoma: a review and proposal. , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[15] R. Soslow,et al. Histologic subtypes of ovarian carcinoma: an overview. , 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[16] S. Blagden,et al. Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer , 2015, Front. Oncol..
[17] Benjamin Haibe-Kains,et al. curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome , 2013, Database J. Biol. Databases Curation.
[18] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[20] K. Cibulskis,et al. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. , 2012, The Journal of clinical investigation.
[21] Francesmary Modugno,et al. Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[22] Ling-Zhi Wang,et al. Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer , 2013, EMBO molecular medicine.
[23] Ie-Ming Shih,et al. The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory , 2010, The American journal of surgical pathology.
[24] Benjamin A. Logsdon,et al. Extracting a low-dimensional description of multiple gene expression datasets reveals a potential driver for tumor-associated stroma in ovarian cancer , 2016, bioRxiv.
[25] Laurent Ozbun,et al. A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. , 2008, Cancer research.
[26] K. Ickstadt,et al. Identifying Interesting Genes with siggenes , 2006 .